- Home
- NDSN vs RVTY Comparison
NDSN vs RVTY Comparison
Compare NDSN & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDSN
- RVTY
- Stock Information
- Founded
- NDSN 1935
- RVTY 1937
- Country
- NDSN United States
- RVTY United States
- Employees
- NDSN N/A
- RVTY N/A
- Industry
- NDSN Industrial Machinery/Components
- RVTY Biotechnology: Laboratory Analytical Instruments
- Sector
- NDSN Industrials
- RVTY Industrials
- Exchange
- NDSN Nasdaq
- RVTY Nasdaq
- Market Cap
- NDSN 10.1B
- RVTY 11.2B
- IPO Year
- NDSN N/A
- RVTY N/A
- Fundamental
- Price
- NDSN $192.62
- RVTY $91.26
- Analyst Decision
- NDSN Strong Buy
- RVTY Buy
- Analyst Count
- NDSN 5
- RVTY 13
- Target Price
- NDSN $256.40
- RVTY $126.08
- AVG Volume (30 Days)
- NDSN 328.8K
- RVTY 1.4M
- Earning Date
- NDSN 05-28-2025
- RVTY 04-28-2025
- Dividend Yield
- NDSN 1.62%
- RVTY 0.31%
- EPS Growth
- NDSN N/A
- RVTY 95.55
- EPS
- NDSN 7.86
- RVTY 2.35
- Revenue
- NDSN $2,672,148,000.00
- RVTY $2,769,868,000.00
- Revenue This Year
- NDSN $4.72
- RVTY $4.83
- Revenue Next Year
- NDSN $4.86
- RVTY $5.99
- P/E Ratio
- NDSN $24.56
- RVTY $39.01
- Revenue Growth
- NDSN 0.79
- RVTY 1.62
- 52 Week Low
- NDSN $165.03
- RVTY $89.36
- 52 Week High
- NDSN $279.38
- RVTY $129.50
- Technical
- Relative Strength Index (RSI)
- NDSN 52.93
- RVTY 40.43
- Support Level
- NDSN $187.89
- RVTY $89.39
- Resistance Level
- NDSN $196.35
- RVTY $94.70
- Average True Range (ATR)
- NDSN 4.20
- RVTY 3.37
- MACD
- NDSN 1.48
- RVTY 0.39
- Stochastic Oscillator
- NDSN 80.86
- RVTY 15.79
About NDSN Nordson Corporation
Nordson manufactures equipment (including pumps, valves, dispensers, applicators, filters, and pelletizers) used for dispensing adhesives, coatings, sealants, and other materials. The firm serves a diverse range of end markets including packaging, medical, electronics, and industrial. Nordson's business is organized into three segments: industrial precision solutions, medical and fluid solutions, and advanced technology solutions. The company generated approximately $2.7 billion in revenue in its fiscal 2024.
About RVTY Revvity Inc.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.